Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonel Trebicka

Showing results (421-430 of 512) with videos related to

Pageof 52
Sort By:
Journal of Hepatology|March 4, 2023
Interferon-induced IL-10 drives systemic T-cell dysfunction during chronic liver injuryCarl-Philipp Hackstein, Jasper Spitzer, Konstantinos Symeonidis, et al.
Cell Reports|February 2, 2023
Neprilysin-dependent neuropeptide Y cleavage in the liver promotes fibrosis by blocking NPY-receptor 1Cristina Ortiz, Sabine Klein, Winfried H Reul, et al.
Frontiers in Physiology|March 29, 2021
Soluble TIM3 and Its Ligands Galectin-9 and CEACAM1 Are in Disequilibrium During Alcohol-Related Liver Disease and Promote Impairment of Anti-bacterial ImmunityAntonio Riva, Elena Palma, Dhruti Devshi, et al.
Nature Immunology|March 8, 2016
Tumor-necrosis factor impairs CD4(+) T cell-mediated immunological control in chronic viral infectionMarc Beyer, Zeinab Abdullah, Jens M Chemnitz, et al.
Nature Communications|July 8, 2022
Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironmentKai Markus Schneider, Antje Mohs, Wenfang Gui, et al.
Clinical and Translational Gastroenterology|July 6, 2026
Short-term mortality is reduced and low grade ACLF reversed by TIPS in patients with fluid overload: a case-control studyEduardo Cervantes-Alvarez, Wenyi Gu, Jonathan Byrtus, et al.
Nature Immunology|July 5, 2020
Publisher Correction: Tumor-necrosis factor impairs CD4<sup>+</sup> T cell-mediated immunological control in chronic viral infectionMarc Beyer, Zeinab Abdullah, Jens M Chemnitz, et al.
JHEP Reports : Innovation in Hepatology|April 10, 2026
Comparative performance of ReMELD-Na, MELD 3.0 and established scores after TIPS for refractory ascites: A multicenter studyMarkus Kimmann, Nancy Farouk, Dominik Bettinger, et al.
Journal of Hepatology|September 8, 2020
Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope ConsortiumElsa Solà, Elisa Pose, Daniela Campion, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 17, 2025
Early Occurrence of Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt Insertion is Linked to Impaired Survival: A Multicenter Cohort StudyMartin A Kabelitz, Lisa Sandmann, Michael Praktiknjo, et al.
Pageof 52

Showing results (421-430 of 512) with videos related to

Sort By:
Pageof 52
Journal of Hepatology|March 4, 2023
Interferon-induced IL-10 drives systemic T-cell dysfunction during chronic liver injuryCarl-Philipp Hackstein, Jasper Spitzer, Konstantinos Symeonidis, et al.
Cell Reports|February 2, 2023
Neprilysin-dependent neuropeptide Y cleavage in the liver promotes fibrosis by blocking NPY-receptor 1Cristina Ortiz, Sabine Klein, Winfried H Reul, et al.
Frontiers in Physiology|March 29, 2021
Soluble TIM3 and Its Ligands Galectin-9 and CEACAM1 Are in Disequilibrium During Alcohol-Related Liver Disease and Promote Impairment of Anti-bacterial ImmunityAntonio Riva, Elena Palma, Dhruti Devshi, et al.
Nature Immunology|March 8, 2016
Tumor-necrosis factor impairs CD4(+) T cell-mediated immunological control in chronic viral infectionMarc Beyer, Zeinab Abdullah, Jens M Chemnitz, et al.
Nature Communications|July 8, 2022
Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironmentKai Markus Schneider, Antje Mohs, Wenfang Gui, et al.
Clinical and Translational Gastroenterology|July 6, 2026
Short-term mortality is reduced and low grade ACLF reversed by TIPS in patients with fluid overload: a case-control studyEduardo Cervantes-Alvarez, Wenyi Gu, Jonathan Byrtus, et al.
Nature Immunology|July 5, 2020
Publisher Correction: Tumor-necrosis factor impairs CD4<sup>+</sup> T cell-mediated immunological control in chronic viral infectionMarc Beyer, Zeinab Abdullah, Jens M Chemnitz, et al.
JHEP Reports : Innovation in Hepatology|April 10, 2026
Comparative performance of ReMELD-Na, MELD 3.0 and established scores after TIPS for refractory ascites: A multicenter studyMarkus Kimmann, Nancy Farouk, Dominik Bettinger, et al.
Journal of Hepatology|September 8, 2020
Endpoints and design of clinical trials in patients with decompensated cirrhosis: Position paper of the LiverHope ConsortiumElsa Solà, Elisa Pose, Daniela Campion, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 17, 2025
Early Occurrence of Hepatic Encephalopathy Following Transjugular Intrahepatic Portosystemic Shunt Insertion is Linked to Impaired Survival: A Multicenter Cohort StudyMartin A Kabelitz, Lisa Sandmann, Michael Praktiknjo, et al.
Pageof 52